之江生物
(688317)
| 流通市值：30.41亿 | | | 总市值：30.41亿 |
| 流通股本：1.90亿 | | | 总股本：1.90亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,451,362,307.24 | 2,422,741,216.05 | 2,552,732,482.86 | 2,460,303,439.58 |
| 交易性金融资产 | 342,944,311.94 | 403,457,640.95 | 347,891,911.73 | 354,296,991.7 |
| 应收票据及应收账款 | 32,578,333.63 | 30,960,718 | 31,792,839.05 | 38,177,764.21 |
| 其中：应收票据 | 690,952.17 | 924,912.28 | 549,571.73 | 1,049,518.77 |
| 应收账款 | 31,887,381.46 | 30,035,805.72 | 31,243,267.32 | 37,128,245.44 |
| 预付款项 | 7,831,678.77 | 6,943,336.07 | 7,615,276.69 | 8,740,740.94 |
| 其他应收款合计 | 475,702.23 | 736,021.47 | 589,026.79 | 4,906,926.31 |
| 存货 | 38,390,479.29 | 49,313,047.12 | 45,572,769.35 | 52,598,737.22 |
| 其他流动资产 | 3,947,835.54 | 4,171.26 | 2,643.22 | 18,833,096.9 |
| 流动资产合计 | 2,877,530,648.64 | 2,914,156,150.92 | 2,986,196,949.69 | 2,937,857,696.86 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 73,196,929.35 | 73,595,821.89 | 64,925,342.94 | 65,509,323.89 |
| 固定资产 | 598,254,079.96 | 610,501,145.04 | 623,305,880.77 | 638,671,493.16 |
| 在建工程 | 249,094.87 | 91,376.15 | 30,458.72 | 2,122,074.59 |
| 使用权资产 | 3,902,652.8 | 4,392,990.18 | 4,886,415.79 | 4,216,264.77 |
| 无形资产 | 26,704,188.01 | 27,617,342.46 | 7,042,607.17 | 6,704,333.99 |
| 商誉 | 5,404,994.34 | 5,404,994.34 | 5,404,994.34 | 5,404,994.34 |
| 长期待摊费用 | 2,862,656.72 | 3,139,389.74 | 3,201,271.27 | 3,216,458.74 |
| 递延所得税资产 | 68,178,131.87 | 67,827,304.49 | 68,806,076.8 | 57,399,174.94 |
| 其他非流动资产 | - | - | 0 | - |
| 非流动资产合计 | 778,752,727.92 | 792,570,364.29 | 777,603,047.8 | 783,244,118.42 |
| 资产总计 | 3,656,283,376.56 | 3,706,726,515.21 | 3,763,799,997.49 | 3,721,101,815.28 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 50,734,417.62 | 53,646,584.64 | 55,403,446.73 | 66,234,189.13 |
| 应付账款 | 50,734,417.62 | 53,646,584.64 | 55,403,446.73 | 66,234,189.13 |
| 合同负债 | 7,555,157.77 | 7,778,039.84 | 8,996,787.69 | 13,170,852.2 |
| 应付职工薪酬 | 34,753,025.36 | 35,726,143.18 | 39,540,101.52 | 36,743,441.58 |
| 应交税费 | 2,910,440.17 | 2,906,474.81 | 3,957,593.72 | 3,072,821.36 |
| 其他应付款合计 | 4,971,077.18 | 5,041,009.09 | 5,898,394.6 | 5,313,950.51 |
| 一年内到期的非流动负债 | 11,503,553.76 | 9,632,546.29 | 11,740,719.37 | 1,667,466.88 |
| 其他流动负债 | 946,226.12 | 974,628.18 | 1,045,798.84 | 1,182,593.21 |
| 流动负债合计 | 113,373,897.98 | 115,705,426.03 | 126,582,842.47 | 127,385,314.87 |
| 非流动负债: | | | | |
| 长期借款 | 279,140,000 | 284,100,000 | 284,262,076.75 | 196,020,000 |
| 租赁负债 | 2,162,999.94 | 2,885,478.86 | 2,964,555.09 | 2,824,632.67 |
| 递延收益 | 985,227.77 | 1,054,044.44 | 1,141,611.11 | 942,094.76 |
| 递延所得税负债 | - | 384,631.63 | 0 | - |
| 非流动负债合计 | 282,288,227.71 | 288,424,154.93 | 288,368,242.95 | 199,786,727.43 |
| 负债合计 | 395,662,125.69 | 404,129,580.96 | 414,951,085.42 | 327,172,042.3 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 192,157,999 | 192,157,999 | 192,157,999 | 192,157,999 |
| 资本公积 | 2,050,702,003.19 | 2,050,702,003.19 | 2,050,702,003.19 | 2,050,702,003.19 |
| 减:库存股 | 339,006,121.47 | 313,174,413.04 | 294,437,636.47 | 255,307,428.88 |
| 其他综合收益 | -12,941,229.75 | -11,876,412.42 | -9,871,458.59 | -8,840,515.87 |
| 盈余公积 | 97,352,175 | 97,352,175 | 97,352,175 | 97,352,175 |
| 未分配利润 | 1,272,356,424.9 | 1,287,435,582.52 | 1,312,945,829.94 | 1,317,865,540.54 |
| 归属于母公司股东权益合计 | 3,260,621,250.87 | 3,302,596,934.25 | 3,348,848,912.07 | 3,393,929,772.98 |
| 股东权益合计 | 3,260,621,250.87 | 3,302,596,934.25 | 3,348,848,912.07 | 3,393,929,772.98 |
| 负债和股东权益合计 | 3,656,283,376.56 | 3,706,726,515.21 | 3,763,799,997.49 | 3,721,101,815.28 |
| 公告日期 | 2026-08-28 | 2026-04-30 | 2026-04-24 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |